FCM
VYGR icon

Farallon Capital Management’s Voyager Therapeutics VYGR Stock Holding History

Farallon Capital Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-715,000
Closed -$2.22M – 165
2025
Q2 		$2.22M Sell
715,000
-1,855,700
-72% -$5.99M 0.01% 85
2025
Q1 		$8.69M Hold
2,570,700
– – 0.04% 76
2024
Q4 		$14.6M Buy
2,570,700
+278,700
+12% +$1.8M 0.06% 77
2024
Q3 		$13.4M Hold
2,292,000
– – 0.06% 86
2024
Q2 		$18.1M Hold
2,292,000
– – 0.08% 76
2024
Q1 		$21.3M Buy
2,292,000
+1,000,000
+77% +$8.44M 0.09% 71
2023
Q4 		$10.9M Hold
1,292,000
– – 0.05% 77
2023
Q3 		$10M Hold
1,292,000
– – 0.05% 89
2023
Q2 		$14.8M Buy
1,292,000
+495,000
+62% +$5.12M 0.07% 84
2023
Q1 		$6.14M Buy
+797,000
New +$6.34M 0.03% 116
2019
Q3 		– Sell
-750,000
Closed -$20.4M – 116
2019
Q2 		$20.4M Sell
750,000
-250,158
-25% -$5.72M 0.13% 78
2019
Q1 		$19.1M Buy
1,000,158
+91,000
+10% +$1.19M 0.14% 74
2018
Q4 		$8.55M Hold
909,158
– – 0.06% 85
2018
Q3 		$17.2M Buy
909,158
+141,001
+18% +$2.71M 0.1% 71
2018
Q2 		$15M Sell
768,157
-121,843
-14% -$2.41M 0.09% 67
2018
Q1 		$16.7M Buy
890,000
+235,188
+36% +$5.08M 0.12% 65
2017
Q4 		$10.9M Buy
654,812
+487,147
+291% +$8.35M 0.09% 66
2017
Q3 		$3.45M Buy
+167,665
New +$1.89M 0.03% 81

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Farallon Capital Management's VYGR Position: Q3 2025 in Review

Farallon Capital Management sold out of Voyager Therapeutics (VYGR) in Q3 2025, closing a stake of 715,000 shares — an estimated $2.22M sold.

Farallon Capital Management first reported a position in VYGR in Q3 2017 and held it in 18 quarters. The position peaked at $21.3M in Q1 2024. 117 funds tracked by Wall St. Rank hold VYGR as of Q3 2025.

  • Farallon Capital Management reported no remaining Voyager Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Farallon Capital Management sold 715,000 Voyager Therapeutics shares in Q3 2025, an estimated $2.22M.
  • Farallon Capital Management first reported a position in Voyager Therapeutics in Q3 2017 and held it in 18 quarters.
  • Farallon Capital Management's Voyager Therapeutics position peaked at $21.3M in Q1 2024.
  • 117 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2025.

Based on Farallon Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.